Antioxidant Effects of Statins via S -Nitrosylation and Activation of Thioredoxin in Endothelial Cells
- 17 August 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 110 (7) , 856-861
- https://doi.org/10.1161/01.cir.0000138743.09012.93
Abstract
Background— HMG-CoA reductase inhibitors (statins) are lipid-lowering drugs that also exert pleiotropic vasculoprotective effects via activation of the endothelial NO synthesis. NO induces S -nitrosylation of target proteins. S -Nitrosylation of the antioxidant enzyme thioredoxin was recently shown to enhance its activity, thereby reducing intracellular reactive oxygen species. Therefore, we investigated whether statins may exert an antioxidant activity in endothelial cells via S -nitrosylation of thioredoxin. Methods and Results— Statins dose- and time-dependently increased the overall level of S -nitrosylated proteins in endothelial cells (atorvastatin 0.1 μmol/L, 206±30% increase; simvastatin 1 μmol/L, 214±19% increase; mevastatin 1 μmol/L, 191±10% increase). The increased S -nitrosylation was blocked by an NO-synthase inhibitor and mevalonate. Moreover, S -nitrosylation of thioredoxin was also significantly augmented after atorvastatin treatment. The atorvastatin-mediated increase in S -nitrosylation was associated with an enhanced enzymatic activity of thioredoxin (atorvastatin, 157±9% increase). This resulted in a significant reduction of intracellular reactive oxygen species within the endothelial cells. In contrast, in endothelial cells overexpressing a thioredoxin construct in which the S -nitrosylation acceptor amino acid cysteine 69 was replaced by serine [TRX(C69S)], atorvastatin did not activate the redox-regulatory activity of thioredoxin. Moreover, overexpression of the non-nitrosylatable thioredoxin TRX(C69S) abolished atorvastatin-mediated reduction of reactive oxygen species. Conclusions— Here, we demonstrate a novel antioxidant mechanism by which statins reduce reactive oxygen species in endothelial cells. Statin-mediated S -nitrosylation of thioredoxin enhanced the enzymatic activity of thioredoxin, resulting in a significant reduction in intracellular reactive oxygen species.Keywords
This publication has 39 references indexed in Scilit:
- Role of oxidative stress in atherosclerosisThe American Journal of Cardiology, 2003
- Fluid Shear Stress Attenuates Hydrogen Peroxide–Induced c-Jun NH 2 -Terminal Kinase Activation via a Glutathione Reductase–Mediated MechanismCirculation Research, 2002
- Redox regulatory and anti-apoptotic functions of thioredoxin depend on S-nitrosylation at cysteine 69Nature Cell Biology, 2002
- Simvastatin Prevents Angiotensin II–Induced Cardiac Alteration and Oxidative StressHypertension, 2002
- Reactive oxygen species, antioxidants, and the mammalian thioredoxin systemPublished by Elsevier ,2001
- Statins as antioxidant therapy for preventing cardiac myocyte hypertrophyJournal of Clinical Investigation, 2001
- HMG‐CoA reductase inhibition protects the diabetic myocardium from ischemia‐reperfusion injuryThe FASEB Journal, 2001
- Lens-Specific Regulation of the Thioredoxin-1 Gene, but Not Thioredoxin-2, upon in Vivo Photochemical Oxidative Stress in the Emory MouseBiochemical and Biophysical Research Communications, 1999
- Suppression of Apoptosis by Nitric Oxide via Inhibition of Interleukin-1β–converting Enzyme (ICE)-like and Cysteine Protease Protein (CPP)-32–like ProteasesThe Journal of Experimental Medicine, 1997
- Extension of Life-Span by Overexpression of Superoxide Dismutase and Catalase in Drosophila melanogasterScience, 1994